Preclinical and ongoing phase I study data of the CHK1 inhibitor BBI-355 in development for patients with oncogene amplification on extrachromosomal DNA (ecDNA) Meeting Abstract
| Authors: | Drilon, A.; Rivera, I. I. R.; Spira, A. I.; Sharma, M. R.; Hansen, R.; Chowdhry, S.; Kasibhatla, S.; Tewari, A.; Weymer, S.; Wagner, K.; Yap, T. A. |
| Abstract Title: | Preclinical and ongoing phase I study data of the CHK1 inhibitor BBI-355 in development for patients with oncogene amplification on extrachromosomal DNA (ecDNA) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S477 |
| Language: | English |
| ACCESSION: | WOS:001087480201024 |
| DOI: | 10.1016/j.annonc.2023.09.1868 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 682P -- Source: Wos |
